SRLS Seracare Life Sciences (MM)

DALLAS, Feb. 23, 2012 /PRNewswire/ -- Securities lawyers at Goldfarb LLP are investigating whether certain officers and directors of SeraCare Life Sciences (NASDAQ: SRLS) violated shareholder protection laws by agreeing to a buyout offer for $4.00 per share to Linden Capital Partners. Concerned SeraCare investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies for this potentially low buyout. 

"This buyout is only an 11.73% premium, well below the average premium of 72.99% over the past two years for transactions in this industry," said Hamilton Lindley. "Additionally, two analysts covering SeraCare stock set a target price of $5 per share. Our proposed shareholder lawsuit seeks to obtain more value for shareholders than the current buyout offer." 

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. SeraCare stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855 with questions or concerns.

Hamilton Lindley

Goldfarb LLP

2501 N. Harwood, Ste. 1801

Dallas, TX 75201

(877) 583-2855 Toll Free Telephone

(214) 583-2233 Local Phone Number

(214) 583-2234 Fax Number

www.goldfarbllp.com

SOURCE Goldfarb LLP